Robert E. Landry Jr.
Net Worth

Last updated:

What is Robert E. Landry Jr. net worth?

The estimated net worth of Mr. Robert E. Landry Jr. is at least $45,661,145 as of 28 Dec 2023. He owns shares worth $18,220,268 as insider, has earned $9,540,877 from insider trading and has received compensation worth at least $17,900,000 in Regeneron Pharmaceuticals, Inc..

What is the salary of Robert E. Landry Jr.?

Mr. Robert E. Landry Jr. salary is $1,790,000 per year as Executive Vice President of Fin. & Chief Financial Officer in Regeneron Pharmaceuticals, Inc..

How old is Robert E. Landry Jr.?

Mr. Robert E. Landry Jr. is 61 years old, born in 1964.

What stocks does Robert E. Landry Jr. currently own?

As insider, Mr. Robert E. Landry Jr. owns shares in one company:

Company Title Shares Price per share Total value
Regeneron Pharmaceuticals, Inc. (REGN) Executive Vice President of Fin. & Chief Financial Officer 31,699 $574.79 $18,220,268

What does Regeneron Pharmaceuticals, Inc. do?

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

REGN logo
REGN
Regeneron Pharmaceuticals, Inc.
$574.79

Robert E. Landry Jr. insider trading

Regeneron Pharmaceuticals, Inc.

Mr. Robert E. Landry Jr. has made 118 insider trades between 2015-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 15,500 units of REGN stock on 8 Jun 2020. As of 28 Dec 2023 he still owns at least 31,699 units of REGN stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 850 $378.98 $322,133
Option
Non-Qualified Stock Option (right to buy) 850 $378.98 $322,133
Option
Non-Qualified Stock Option (right to buy) 750 $378.98 $284,235
Option
Common Stock 750 $378.98 $284,235
Option
Common Stock 1,000 $378.98 $378,980
Option
Non-Qualified Stock Option (right to buy) 1,000 $378.98 $378,980
Sale
Common Stock 223 $844 $188,212
Sale
Common Stock 115 $820.85 $94,398
Sale
Common Stock 10 $818.81 $8,188
Sale
Common Stock 31 $826.36 $25,617
Sale
Common Stock 142 $821.4 $116,639
Sale
Common Stock 243 $825.37 $200,565
Sale
Common Stock 128 $822.67 $105,302
Sale
Common Stock 181 $823.6 $149,072
Sale
Common Stock 157 $824.54 $129,453
Sale
Common Stock 7 $830.01 $5,810
Option
Non-Qualified Stock Option (right to buy) 800 $381.92 $305,536
Option
Common Stock 800 $381.92 $305,536
Sale
Common Stock 39 $819.47 $31,959
Sale
Common Stock 50 $820.46 $41,023
Option
Non-Qualified Stock Option (right to buy) 3,000 $378.98 $1,136,940
Sale
Common Stock 18 $822.57 $14,806
Option
Common Stock 3,000 $378.98 $1,136,940
Sale
Common Stock 4 $824.3 $3,297
Sale
Common Stock 13 $825.59 $10,733
Sale
Common Stock 4 $829.16 $3,317
Sale
Common Stock 48 $821.39 $39,427
Sale
Common Stock 99 $788.62 $78,073
Sale
Common Stock 2 $793.33 $1,587
Sale
Common Stock 99 $794.61 $78,666
Sale
Common Stock 59 $795.41 $46,929
Sale
Common Stock 49 $789.05 $38,663
Sale
Common Stock 10 $790.41 $7,904
Sale
Common Stock 51 $783.05 $39,936
Sale
Common Stock 28 $797.43 $22,328
Sale
Common Stock 18 $796.43 $14,336
Sale
Common Stock 85 $786.45 $66,848
Sale
Common Stock 58 $787.47 $45,673
Sale
Common Stock 113 $784.27 $88,623
Sale
Common Stock 3 $791 $2,373
Sale
Common Stock 78 $785.88 $61,299
Option
Non-Qualified Stock Option (right to buy) 3,000 $381.92 $1,145,760
Sale
Common Stock 739 $764.5 $564,966
Option
Common Stock 3,000 $381.92 $1,145,760
Option
Non-Qualified Stock Option (right to buy) 3,000 $381.92 $1,145,760
Option
Common Stock 3,000 $381.92 $1,145,760
Sale
Common Stock 12 $760.19 $9,122
Sale
Common Stock 582 $756.5 $440,283
Sale
Common Stock 16 $759.9 $12,158
Option
Non-Qualified Stock Option (right to buy) 2,500 $381.92 $954,800
Option
Common Stock 2,500 $381.92 $954,800
Sale
Common Stock 17 $762.92 $12,970
Sale
Common Stock 19 $763.1 $14,499
Sale
Common Stock 70 $759.39 $53,157
Sale
Common Stock 13 $760.9 $9,892
Sale
Common Stock 1 $750 $750
Sale
Common Stock 40 $753.23 $30,129
Sale
Common Stock 119 $761.36 $90,602
Sale
Common Stock 80 $754.39 $60,351
Sale
Common Stock 81 $755.46 $61,192
Sale
Common Stock 42 $758.2 $31,844
Option
Non-Qualified Stock Option (right to buy) 2,000 $381.92 $763,840
Option
Common Stock 2,000 $381.92 $763,840
Sale
Common Stock 358 $739.5 $264,741
Option
Common Stock 1,500 $381.92 $572,880
Option
Non-Qualified Stock Option (right to buy) 1,500 $381.92 $572,880
Option
Non-Qualified Stock Option (right to buy) 6,000 $381.92 $2,291,520
Sale
Common Stock 74 $729.76 $54,002
Sale
Common Stock 37 $731.6 $27,069
Sale
Common Stock 22 $732.56 $16,116
Sale
Common Stock 1,226 $733.52 $899,296
Sale
Common Stock 75 $734.53 $55,090
Sale
Common Stock 149 $735.36 $109,569
Sale
Common Stock 189 $736.61 $139,219
Sale
Common Stock 22 $737.89 $16,234
Sale
Common Stock 68 $738.63 $50,227
Option
Non-Qualified Stock Option (right to buy) 1,500 $399.66 $599,490
Option
Non-Qualified Stock Option (right to buy) 2,000 $399.66 $799,320
Option
Common Stock 6,000 $381.92 $2,291,520
Option
Common Stock 2,000 $399.66 $799,320
Sale
Common Stock 31 $745.27 $23,103
Sale
Common Stock 56 $744.52 $41,693
Sale
Common Stock 32 $743.71 $23,799
Sale
Common Stock 28 $740.98 $20,747
Sale
Common Stock 29 $739.02 $21,432
Sale
Common Stock 43 $735.12 $31,610
Sale
Common Stock 44 $733.38 $32,269
Sale
Common Stock 16 $729.67 $11,675
Sale
Common Stock 30 $728.77 $21,863
Sale
Common Stock 16 $724.33 $11,589
Option
Non-Qualified Stock Option (right to buy) 1,500 $399.66 $599,490
Sale
Common Stock 15 $701.98 $10,530
Sale
Common Stock 301 $695.5 $209,346
Option
Common Stock 1,500 $399.66 $599,490
Sale
Common Stock 226 $691.47 $156,272
Option
Non-Qualified Stock Option (right to buy) 1,250 $555.67 $694,588
Sale
Common Stock 147 $692.38 $101,780
Option
Non-Qualified Stock Option (right to buy) 4,000 $399.66 $1,598,640
Sale
Common Stock 103 $693.18 $71,398
Option
Non-Qualified Stock Option (right to buy) 3,500 $399.66 $1,398,810
Option
Non-Qualified Stock Option (right to buy) 4,500 $399.66 $1,798,470
Sale
Common Stock 37 $690.91 $25,564
Sale
Common Stock 205 $689.33 $141,313
Sale
Common Stock 542 $688.55 $373,194
Sale
Common Stock 147 $694.94 $102,156
Sale
Common Stock 220 $687.52 $151,254
Sale
Common Stock 192 $686.67 $131,841
Sale
Common Stock 176 $685.58 $120,662
Sale
Common Stock 304 $683.29 $207,720
Sale
Common Stock 227 $684.45 $155,370
Sale
Common Stock 103 $682.37 $70,284
Sale
Common Stock 54 $681.9 $36,823
Option
Non-Qualified Stock Option (right to buy) 1,250 $555.67 $694,588
Option
Common Stock 4,000 $399.66 $1,598,640
Option
Common Stock 4,500 $399.66 $1,798,470
Option
Common Stock 3,500 $399.66 $1,398,810
Option
Common Stock 1,250 $555.67 $694,588
Option
Common Stock 1,250 $555.67 $694,588
Sale
Common Stock 300 $693 $207,900
Option
Non-Qualified Stock Option (right to buy) 400 $381.92 $152,768
Option
Common Stock 400 $381.92 $152,768
Option
Non-Qualified Stock Option (right to buy) 365 $381.92 $139,401
Option
Common Stock 365 $381.92 $139,401
Sale
Common Stock 83 $686 $56,938
Sale
Common Stock 300 $677 $203,100
Sale
Common Stock 116 $662.5 $76,850
Option
Non-Qualified Stock Option (right to buy) 1,500 $555.67 $833,505
Option
Common Stock 1,500 $555.67 $833,505
Option
Non-Qualified Stock Option (right to buy) 4,250 $399.66 $1,698,555
Sale
Common Stock 781 $664.66 $519,103
Option
Common Stock 4,250 $399.66 $1,698,555
Option
Non-Qualified Stock Option (right to buy) 3,750 $399.66 $1,498,725
Sale
Common Stock 681 $645.08 $439,299
Option
Common Stock 3,750 $399.66 $1,498,725
Option
Common Stock 1,000 $555.67 $555,670
Option
Non-Qualified Stock Option (right to buy) 1,000 $555.67 $555,670
Sale
Common Stock 537 $615.48 $330,510
Option
Non-Qualified Stock Option (right to buy) 3,000 $381.92 $1,145,760
Option
Common Stock 3,000 $381.92 $1,145,760
Sale
Common Stock 364 $619.54 $225,511
Option
Non-Qualified Stock Option (right to buy) 2,000 $381.92 $763,840
Option
Common Stock 2,000 $381.92 $763,840
Sale
Common Stock 696 N/A N/A
Sale
Common Stock 391 N/A N/A
Sale
Common Stock 391 $652.75 $255,225
Option
Common Stock 8,500 $477.67 $4,060,153
Option
Common Stock 8,500 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 8,500 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 8,500 $477.67 $4,060,153
Sale
Common Stock 579 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 3,000 N/A N/A
Option
Common Stock 3,000 N/A N/A
Sale
Common Stock 134 $648.38 $86,883
Sale
Common Stock 1,160 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 12,500 N/A N/A
Option
Common Stock 12,500 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 12,500 $477.67 $5,970,813
Sale
Common Stock 81 $614.06 $49,738
Sale
Common Stock 400 N/A N/A
Sale
Common Stock 512 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 8,900 N/A N/A
Option
Common Stock 8,900 N/A N/A
Sale
Common Stock 988 N/A N/A
Sale
Common Stock 199 N/A N/A
Option
Common Stock 3,500 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 3,500 N/A N/A
Sale
Common Stock 4,271 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 15,500 N/A N/A
Option
Common Stock 15,500 N/A N/A
Sale
Common Stock 3,250 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 12,500 N/A N/A
Sale
Common Stock 991 N/A N/A
Option
Common Stock 12,500 N/A N/A
Option
Common Stock 4,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 4,000 N/A N/A
Sale
Common Stock 853 N/A N/A
Option
Common Stock 3,500 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 3,500 N/A N/A
Sale
Common Stock 828 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 3,500 N/A N/A
Option
Common Stock 3,500 N/A N/A
Sale
Common Stock 696 N/A N/A
Option
Common Stock 3,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 3,000 N/A N/A
Sale
Common Stock 683 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 3,000 N/A N/A
Sale
Common Stock 1,353 N/A N/A
Option
Common Stock 3,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 6,000 N/A N/A
Sale
Common Stock 600 N/A N/A
Option
Common Stock 6,000 N/A N/A
Sale
Common Stock 200 N/A N/A
Option
Common Stock 1,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 1,000 N/A N/A
Sale
Common Stock 214 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 1,000 N/A N/A
Option
Common Stock 1,000 N/A N/A
Sale
Common Stock 107 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 500 N/A N/A
Option
Common Stock 500 N/A N/A
Sale
Common Stock 474 N/A N/A
Sale
Common Stock 189 N/A N/A
Option
Common Stock 3,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 3,000 N/A N/A
Sale
Common Stock 427 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 2,000 N/A N/A
Sale
Common Stock 468 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 2,000 N/A N/A
Sale
Common Stock 526 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 4,000 N/A N/A
Option
Common Stock 4,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A